Home » International Scholarships for Students » FRAXA Research Foundation Fellowships

FRAXA Research Foundation Fellowships

The FRAXA Research Foundation invites applications for Fellowships, Clinical Trial Grants, and Curative Therapy Research projects focused on Fragile X syndrome. Fellowship applications are due February 1, 2026.

Applicants from any country may apply through a university, hospital, or non-profit research institution. Projects must focus specifically on Fragile X syndrome, with priority given to translational, clinical, or curative research. A Letter of Intent to FRAXA’s Chief Scientific Officer is required before submitting an application, and fellowship proposals are limited to one per laboratory.

  • Award
  • Application Process
  • Clarity of Information
4.3
Sending
User Review
0 (0 votes)

FRAXA Research Foundation is a nonprofit organization dedicated to finding effective treatments and ultimately a cure for Fragile X syndrome. It funds high-impact research worldwide, with a strong focus on translational studies, clinical trials, and curative therapies that can move quickly into medical practice. FRAXA prioritizes projects with clear practical applications and works to accelerate progress by removing key bottlenecks in Fragile X research.

Application Deadline: February 2, 2026

Brief Description

  • University or Organization: FRAXA Research Foundation
  • Department: Biomedical & Translational Research (Fragile X Syndrome)
  • Course Level: Postdoctoral / Research Fellowship / Clinical Research
  • Award:

  • FRAXA Fellowship: $100,000 over 2 years ($50,000 per year)

  • Curative Therapies Grant: Up to $100,000 per year

  • Clinical Trial Grants: Flexible funding amount

  • Access Mode: Online

  • Number of Awards: NA
  • Nationality: Domestic and international
  • The Award Can Be Taken In: United States

Eligibility

  • Eligible Countries: All countries
  • Acceptable Course or Subjects: The scholarship will be awarded in Fragile X–related research, including:

  • Clinical trials involving human Fragile X participants

  • Curative therapies (gene therapy, gene repair/reactivation, ASOs, mRNA therapeutics, protein replacement)

  • Translational and preclinical Fragile X research

  • Admissible Criteria: To be eligible, applicants must meet the following criteria:

  • Applicants must be affiliated with a university, hospital, or non-profit research laboratory

  • Research must be focused explicitly on Fragile X syndrome

  • Fellowship applicants must demonstrate adequate institutional and laboratory support

  • Only one application per lab group is permitted for fellowships

  • Proposed model systems (animal or cellular) must already be established in-house

  • A Letter of Intent to Dr. Michael Tranfaglia (Chief Scientific Officer) is mandatory before submitting any application.

How to Apply

  • Submit the complete application as a single PDF via email to:

  • Applications must include project details, scientific proposal, budget, CVs, references, and funding disclosures

  • Clinical Trial & Curative Therapy proposals: Accepted year-round

Benefits

  • Substantial funding support for high-impact Fragile X research

  • Flexible use of funds (salary, personnel, supplies, research costs)

  • Global eligibility with international research collaboration opportunities

  • Priority consideration for projects with direct clinical or curative potential

Apply Now